Evidence map›Paper›PMID 29427413›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

TGF-β1 Suppresses the Type I IFN Response and Induces Mitochondrial Dysfunction in Alveolar Macrophages.

Jocelyn R Grunwell, Samantha M Yeligar, Susan Stephenson, Xiao Du Ping, Theresa W Gauthier, Anne M Fitzpatrick, Lou Ann S Brown

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 66 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Monocyte-mediated mechanisms in idiopathic pulmonary fibrosis: opportunities for early intervention.Apoptosis : an international journal on programmed cell death · 2026
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. TGF-β signaling in health, disease, and therapeutics.Signal transduction and targeted therapy · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jocelyn R GrunwellDivision of Critical Care Medicine, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322; jgrunwe@emory.edu.ORCID 0000-0003-4289-6469
Samantha M YeligarDivision of Pulmonary, Allergy, Critical Care and Sleep, Department of Medicine, Emory University, Atlanta, GA 30322.ORCID 0000-0001-9309-0233
Susan StephensonDivision of Pulmonary, Allergy and Sleep Medicine, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322; and.ORCID 0000-0003-4202-1929
Xiao Du PingDivision of Neonatology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322.
Theresa W GauthierDivision of Neonatology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322.
Anne M FitzpatrickDivision of Pulmonary, Allergy and Sleep Medicine, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322; and.
Lou Ann S BrownDivision of Neonatology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322.
Emory University · US

Funding

Critical Care Training ProgramT32GM095442 · NIGMS · EMORY UNIVERSITY · PI Craig M Coopersmith · 2011 to 2026
$4.7M
Effect of PPARy Ligands on Alcohol-Induced Alveolar Macrophage Oxidative StressR00AA021803 · NIAAA · EMORY UNIVERSITY · PI YELIGAR, SAMANTHA M. · 2016 to 2018
$747k
NIAAA NIH HHS R00 AA021803NIGMS NIH HHS T32 GM095442
6 · The paper itself

Abstract

TGF-β1 is a pleiotropic cytokine with an established role in fibrosis; however, the immunosuppressive effects of TGF-β1 are less characterized. Elevated levels of TGF-β1 are found in patients with acute and chronic lung diseases, and the underlying disease processes are exacerbated by respiratory viral infections. The alveolar macrophage is the first line of cellular defense against respiratory viral infections, and its response to infections is dependent on environmental cues. Using the mouse alveolar macrophage line, MH-S, and human CD14

Indexed as

Adenosine TriphosphateAnimalsApoptosisCell LineCytokinesHumansInflammationInterferon Type IMacrophages, AlveolarMiceMitochondriaRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsSignal TransductionTransforming Growth Factor beta1Adenosine TriphosphateCytokinesInterferon Type ITransforming Growth Factor beta1

Identifiers

PMID29427413
PMCPMC5928790
OpenAlexW2787435977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.